Open access
Oct 2026
Neoadjuvant Chemo-Immunotherapy Yields Survival Comparable to Upfront Surgery in Metaplastic Breast Cancer: A National Cancer Database Analysis.
OBJECTIVE Metaplastic breast carcinoma (MpBC) is a rare and aggressive subtype of breast cancer, often characterized by triple-negative (TN) receptor status and a limited response to standard chemotherapy. The optimal treatment strategy remains undefined. This study evaluates overall survival (OS) in patients with TN-M...
M. Nelis, Lily Zhang, V. Gadi et al.
· Annals of Surgical Oncology · 0 citations